---
$id: https://graph.org.ai/products/commodity/51302307
$type: Product
source: UNSPSC
code: "51302307"
title: "Croconazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Croconazole

**UNSPSC Code**: 51302307
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C18H15CLN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 446254H55G. European Medicines Agency schedules croconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06821MIG. The term CROCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26. ). CROCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule croconazole under HS 29332990 and SITC 51573. As of Q4 2014, CROCONAZOLE remains the US FDA Preferred Term for this commodity. Croconazole bears US NLM identifiers UMLS ID C0056504 and NCI Concept Code C78037. SMILES: C=C(C1=CC=CC=C1OCC2=CC(=CC=C2)CL)N3C=CN=C3.

